Company Filing History:
Years Active: 2025
Title: Catherine Sierra: Innovator in Antibody Research
Introduction
Catherine Sierra is a prominent inventor based in Seattle, WA (US). She has made significant contributions to the field of biotechnology, particularly in the development of antibodies and chimeric antigen receptors.
Latest Patents
Catherine holds a patent for "Antibodies and chimeric antigen receptors specific for receptor tyrosine kinase like orphan receptor 1 (ROR1)." This patent includes receptor tyrosine kinase-like orphan receptor 1 (ROR1)-binding molecules, specifically human antibodies that target ROR1, including antibody fragments. The patent also covers recombinant receptors, such as chimeric antigen receptors (CARs) that incorporate these antibodies or fragments, along with polynucleotides encoding the antibodies, antigen-binding fragments, or receptors specific for ROR1. Furthermore, it discusses genetically engineered cells containing ROR1-binding proteins and receptors, along with related methods and applications in adoptive cell therapy.
Career Highlights
Catherine is currently associated with Juno Therapeutics GmbH, where she continues her innovative work in the field of immunotherapy. Her research focuses on advancing therapeutic options for cancer treatment through the use of engineered antibodies.
Collaborations
Catherine collaborates with notable colleagues, including Andreia Costa and Rupesh Amin, who contribute to her research endeavors.
Conclusion
Catherine Sierra is a trailblazer in antibody research, with a patent that holds promise for advancements in cancer therapy. Her work at Juno Therapeutics GmbH exemplifies her commitment to innovation in biotechnology.